Companies · Other Health Care

SentiAR, Inc.

St. Louis · Other Health Care

Diligence memoA one-page analyst read on SentiAR, Inc. — recommendation, valuation, rhythm, risks.
$15.2M
Total raised · real
5
Rounds
0.4×
Latest step-up
Top 20%
Sector rank · raised
Series A
Latest stage · inferred · Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

SentiAR, Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.54× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
Active
  • Last raise 14 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

SentiAR, Inc. is one of 5376 Other Health Care companies tracked from St. Louis. By capital raised it ranks in the upper tier (ahead of 81% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
20
Investors (latest)
2025-04-28
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2017-06-15 Raised $300K (real) Modeled valuation $9.2M (est)$300K$9.2MPre-Seed2017Pre-Seed · 2018-04-11 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2018Series A · 2020-01-24 Raised $5.6M (real) Modeled valuation $113M (est)$5.6M$113MSeries A2020Seed · 2020-01-24 Raised $3.0M (real) Modeled valuation $74M (est)$3.0M$74MSeed2020Series A · 2022-10-26 Raised $5.8M (real) Modeled valuation $51M (est)$5.8M$51MSeries A2022Series A · 2025-04-28 Raised $2.5M (real) Modeled valuation $8.8M (est)$2.5M$8.8MSeries A2025+$1.0M+$5.6M+$3.0M+$5.8M+$2.5MCumulative $18M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$300K · 2017
Pre-Seed extension$1.0M · 2018
Series A$5.6M · 2020no Seed on file
Bridge · Series A-stage$3.0M · 2020smaller follow-on
Series A extension$5.8M · 2022
Series A extension$2.5M · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$8.8M
Base estimate est.
$3.2M
Conservative case
$15.8M
Upside case
$11.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $9.2M · 2017-06-152017Pre-Seed · modeled $30.8M · 2018-04-11Series A · modeled $113.0M · 2020-01-24Seed · modeled $74.4M · 2020-01-24Series A · modeled $51.0M · 2022-10-26Series A · modeled $8.8M · 2025-04-282025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
1.2 yr
Elapsed time used
1.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
19 mo
Avg between rounds
$1.9M/yr
Capital velocity
9.0 yr
On record since
2017
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.2× above median
This company$15.2M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.4× of median
This company$2.5M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.4× of median
This company$8.8M
Sector median$22.1M

Raised more than 81% of sector peers (real $). Modeled value above 32% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #54 of 83.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)HelloJoy, Inc. · Series A Raised $26.3M · modeled $55.0M (est)Maui Imaging, Inc. · Series A Raised $29.9M · modeled $51.0M (est)Celltrio, Inc. · Series A Raised $15.0M · modeled $50.8M (est)Medmo, Inc. · Series A Raised $31.7M · modeled $44.7M (est)Vertical Orthopaedics, Inc. · Series A Raised $16.7M · modeled $44.0M (est)AbriCare, Inc. · Series A Raised $15.0M · modeled $39.1M (est)WP Stillwater, LLC · Series A Raised $14.3M · modeled $38.1M (est)Sylke, Inc. · Series A Raised $15.9M · modeled $37.6M (est)Iridex Corp · Series A Raised $10.0M · modeled $37.2M (est)2GHealth Inc. · Series A Raised $17.5M · modeled $35.6M (est)Okc Alf 4, Llc · Series A Raised $8.9M · modeled $34.5M (est)HC Jones, Inc. · Series A Raised $14.1M · modeled $33.4M (est)SentiAR, Inc. (this company) Raised $15.2M · modeled $8.8M (est)SentiAR, Inc.
CompanyStageRaised · realValue · estvs peer med.
HelloJoy, Inc.Series A$26.3M$55.0M3.37×
Maui Imaging, Inc.Series A$29.9M$51.0M3.12×
Celltrio, Inc.Series A$15.0M$50.8M3.11×
Medmo, Inc.Series A$31.7M$44.7M2.74×
Vertical Orthopaedics, Inc.Series A$16.7M$44.0M2.69×
AbriCare, Inc.Series A$15.0M$39.1M2.39×
WP Stillwater, LLCSeries A$14.3M$38.1M2.33×
Sylke, Inc.Series A$15.9M$37.6M2.30×
Iridex CorpSeries A$10.0M$37.2M2.28×
2GHealth Inc.Series A$17.5M$35.6M2.18×
Okc Alf 4, LlcSeries A$8.9M$34.5M2.11×
HC Jones, Inc.Series A$14.1M$33.4M2.04×
SentiAR, Inc. this companySeries A$15.2M$8.8M0.54×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$300K2017-06-15$1.7M$9.2M90%
Pre-Seed$1.0M2018-04-11$5.6M$30.8M90%
Series A$5.6M2020-01-24$25.4M$113.0M90%
Seed$3.0M2020-01-24$15.0M$74.4M90%
Series A$5.8M2022-10-26$26.4M$51.0M90%
Series A$2.5M2025-04-28$11.2M$8.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$300K2017-06-15
    • First recorded raise — entered as Pre-Seed.
    • 4 investors on this round.
  2. Pre-Seed$1.0M2018-04-11
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 3.3× larger than the prior — scaling up.
    • 4 investors on this round.
  3. Series A$5.6M2020-01-24
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 5.6× larger than the prior — scaling up.
    • 15 investors on this round.
  4. Seed$3.0M2020-01-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.9× smaller than the prior — bridge or down round.
    • 10 investors on this round.
  5. Series A$5.8M2022-10-26
    • Raised again after 33 mo — slower than the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 15 investors on this round.
  6. Series A$2.5M2025-04-28
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 20 investors on this round.
Intelligence
2026 ~Q4
Modeled next raise · ~19mo cadence
$2.5M
Modeled next size est.range $2.5M$3.9M
0.4×
Last step-up
$1.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
WILLIAM SCHMIDT6 other2020-01
Sean Churchill2 other2022-10
Warren Watson2 other2022-10
James Patrick Howard1 other2017-06
Berk Tas2020-01
Charles Patrick Bolten2018-04
Charlie Bolten2020-01
Jennifer Patrick Silva2018-04
Jen Silva2022-10
Jonathan Patrick Silva2018-04
Jonathan Silva2025-04
Jon Silva2020-01
Shlomo Shpun2022-10
William Patrick Schmidt2018-04
Registry & provenance

SentiAR, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1713831
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Cardialen, Inc.Other Health CareSeries B$28.2M$71.8Mnetwork2 shared operators · same sector
EnduraCare Acute Care Services, LLCOther Health CareSeries A$14.6M$10.1Msame sector · same stage
Perfusio Corp.Other Health CareSeries A$16.4M$9.3Msame sector · same stage
SweetBio, Inc.Other Health CareSeries A$13.6M$7.7Msame sector · same stage
Project Belle LLCOther Health CareSeries A$12.8M$7.4Msame sector · same stage
iOR Holdings, Inc.Other Health CareSeries A$18.0M$8.7Msame sector · same stage
Avalon GloboCare Corp.Other Health CareSeries A$12.7M$8.6Msame sector · same stage
FPPS Holdings, LLCOther Health CareSeries A$19.0M$7.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Sente IncOther Health CareSeries A$171.2M90%
SentryHealth Inc.Other Health CareSeed$56.8M90%
Sentia Wellness, Inc.PharmaceuticalsSeries C$3.2B85%
Cardia, Inc.Other Health CareSeed$9.0M85%
ReadCoor, Inc.Other Health CareSeries B$593.7M84%
Livmor Inc.Other Health CarePre-Seed$2.7M84%
Caremerge, Inc.Other Health CareSeries A$104.7M84%
Calidar, Inc.Other Health CarePre-Seed$3.8M84%
Frequently asked
How much funding has SentiAR, Inc. raised?
SentiAR, Inc. has raised approximately $15.2M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is SentiAR, Inc.'s estimated valuation?
Provath's modeled valuation for SentiAR, Inc. is approximately $8.8M (modeled range $3.2M–$15.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is SentiAR, Inc. at?
SentiAR, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Apr 28.
What does SentiAR, Inc. do and where is it based?
SentiAR, Inc. operates in the Other Health Care sector, based in St. Louis.
Explore related

See where SentiAR, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at SentiAR, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.